Literature DB >> 12183669

Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.

Guoping Cai1, Hoau-Yan Wang, Eitan Friedman.   

Abstract

Chronic interruption of the nigrostriatal dopaminergic pathway leads to sensitized dopaminergic responses in striatum. We attempted to explore the mechanism(s) underlying this dopaminergic supersensitivity by assessing dopamine receptor signaling and receptor-G protein coupling in unilateral 6-hydroxydopamine-lesioned rats. Dopamine-stimulated adenylyl cyclase activity as well as dopamine-activated guanosine 5'-O-(3-[(35)S]thiotriphosphate) ([(35)S]GTPgammaS) binding and [(3)H]palmitate incorporation by Galpha proteins were enhanced in tissues obtained from denervated striata without apparent changes in Galpha protein levels. Moreover, high-affinity binding sites of the D(1) dopamine receptor increased in lesioned compared with control striata without altering the expression level of the receptor. These denervation-mediated changes appear to correlate with the increase in D(1) dopamine receptor binding sites that co-immunoprecipitated with Galphas(olf)/q(11) proteins. In contrast, the total number of D(2) receptor binding sites was increased, yielding an increase in absolute number of high-affinity sites without significant changes in the proportion of high-affinity sites. Stimulation of the D(2) dopamine receptor enhanced coupling to Galphai protein; this was increased in the striata lesioned. The results provide an important molecular mechanism by which dopamine receptor-regulated signaling is enhanced following denervation of dopaminergic input to striatum. Although D(1) dopamine receptor supersensitivity appears to be mediated by enhanced coupling of the receptor to its G proteins, sensitization in the D(2) dopamine receptor system is mediated by increased D(2) receptor density and enhanced D(2) receptor-Gi protein coupling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183669     DOI: 10.1124/jpet.102.036673

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

Review 1.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  Tumoural denervation of the nigrostriatal pathway.

Authors:  Martin Victor Añaños; Teresa Baringo; Paola Lievano; Leticia De la Cueva; Pablo Navarro; Estela Arroyo; Mario Gonzalez; Dolores Abos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-24       Impact factor: 9.236

3.  Removal of endogenous neuromodulators in a small motor network enhances responsiveness to neuromodulation.

Authors:  Kawasi M Lett; Veronica J Garcia; Simone Temporal; Dirk Bucher; David J Schulz
Journal:  J Neurophysiol       Date:  2017-06-28       Impact factor: 2.714

4.  The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.

Authors:  Szabolcs Farkas; Katalin Nagy; Zhisheng Jia; Tibor Harkany; Miklós Palkovits; Sean R Donohou; Victor W Pike; Christer Halldin; Domokos Máthé; László Csiba; Balázs Gulyás
Journal:  Brain Res Bull       Date:  2012-03-07       Impact factor: 4.077

5.  Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output.

Authors:  Shengyuan Ding; Li Li; Fu-Ming Zhou
Journal:  J Neurophysiol       Date:  2014-12-30       Impact factor: 2.714

6.  Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

Authors:  Jean-Christophe Corvol; Marie-Paule Muriel; Emmanuel Valjent; Jean Féger; Naïma Hanoun; Jean-Antoine Girault; Etienne C Hirsch; Denis Hervé
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

7.  Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.

Authors:  Kristin B Dupre; Karen L Eskow; Christopher J Barnum; Christopher Bishop
Journal:  Neuropharmacology       Date:  2008-09-10       Impact factor: 5.250

8.  Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats.

Authors:  Abesh Kumar Bhattacharjee; Lisa Chang; Laura White; Richard P Bazinet; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2008-02-15       Impact factor: 4.530

9.  Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Authors:  Abesh K Bhattacharjee; Lisa Chang; Mei Chen; Laura White; Jane M Bell; Richard P Bazinet; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

10.  GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs.

Authors:  Daniela Marazziti; Silvia Mandillo; Chiara Di Pietro; Elisabetta Golini; Rafaele Matteoni; Glauco P Tocchini-Valentini
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.